Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua L Fuqua

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Antimicrobial Agents and Chemotherapy|April 2, 2020
Rapid-Release Griffithsin Fibers for Dual Prevention of HSV-2 and HIV-1 InfectionsKevin M Tyo, Amanda B Lasnik, Longyun Zhang, et al.
Frontiers in Bioengineering and Biotechnology|August 9, 2018
Technoeconomic Modeling of Plant-Based Griffithsin ManufacturingAatif Alam, Linda Jiang, Gregory A Kittleson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 9, 2020
Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infectionsKevin M Tyo, Amanda B Lasnik, Longyun Zhang, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 11, 2013
Conformal ceramic electrodes that record glutamate release and corresponding neural activity in primate prefrontal cortexRobert E Hampson, Joshua L Fuqua, Peter F Huettl, et al.
Peptides|January 11, 2014
Dynamic changes in dopamine neuron function after DNSP-11 treatment: effects in vivo and increased ERK 1/2 phosphorylation in vitroJoshua L Fuqua, Ofelia M Littrell, Martin Lundblad, et al.
AAPS Pharmscitech|February 24, 2021
Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV PreventionLindsay F Kramzer, Krystal T Hamorsky, Phillip W Graebing, et al.
Scientific Reports|September 15, 2021
Serological assessment of SARS-CoV-2 infection during the first wave of the pandemic in Louisville KentuckyKrystal T Hamorsky, Adrienne M Bushau-Sprinkle, Kathleen Kitterman, et al.
The Journal of Infectious Diseases|February 11, 2020
Griffithsin Inhibits Nipah Virus Entry and Fusion and Can Protect Syrian Golden Hamsters From Lethal Nipah Virus ChallengeMichael K Lo, Jessica R Spengler, Lauren R H Krumpe, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Antimicrobial Agents and Chemotherapy|April 2, 2020
Rapid-Release Griffithsin Fibers for Dual Prevention of HSV-2 and HIV-1 InfectionsKevin M Tyo, Amanda B Lasnik, Longyun Zhang, et al.
Frontiers in Bioengineering and Biotechnology|August 9, 2018
Technoeconomic Modeling of Plant-Based Griffithsin ManufacturingAatif Alam, Linda Jiang, Gregory A Kittleson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 9, 2020
Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infectionsKevin M Tyo, Amanda B Lasnik, Longyun Zhang, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 11, 2013
Conformal ceramic electrodes that record glutamate release and corresponding neural activity in primate prefrontal cortexRobert E Hampson, Joshua L Fuqua, Peter F Huettl, et al.
Peptides|January 11, 2014
Dynamic changes in dopamine neuron function after DNSP-11 treatment: effects in vivo and increased ERK 1/2 phosphorylation in vitroJoshua L Fuqua, Ofelia M Littrell, Martin Lundblad, et al.
AAPS Pharmscitech|February 24, 2021
Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV PreventionLindsay F Kramzer, Krystal T Hamorsky, Phillip W Graebing, et al.
Scientific Reports|September 15, 2021
Serological assessment of SARS-CoV-2 infection during the first wave of the pandemic in Louisville KentuckyKrystal T Hamorsky, Adrienne M Bushau-Sprinkle, Kathleen Kitterman, et al.
The Journal of Infectious Diseases|February 11, 2020
Griffithsin Inhibits Nipah Virus Entry and Fusion and Can Protect Syrian Golden Hamsters From Lethal Nipah Virus ChallengeMichael K Lo, Jessica R Spengler, Lauren R H Krumpe, et al.
Pageof 2